Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CLK inhibitors(Clk dual-specificity kinases inhibitors), Wnt signalling pathway modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinued |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mantle-Cell Lymphoma | Preclinical | US | 13 Nov 2019 |